Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach-Reference-Cited by-同舟云学术

Role of the Adipocyte, Free Fatty Acids, and Ectopic Fat in Pathogenesis of Type 2 Diabetes Mellitus: Peroxisomal Proliferator-Activated Receptor Agonists Provide a Rational Therapeutic Approach

Published:2004-02-01 Issue:2 Volume:89 Page:463-478
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

Bays Harold¹,Mandarino Lawrence²,DeFronzo Ralph A.²

Affiliation:

1. Louisville Metabolic and Atherosclerosis Research Center (H.B.), Louisville, Kentucky 40213

2. Diabetes Division, University of Texas Health Science Center (L.M., R.A.D.), San Antonio, Texas 78229

Publisher

The Endocrine Society

Subject

Biochemistry (medical),Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/89/2/463/10742257/jcem0463.pdf

Reference334 articles.

1. Lilly Lecture. The triumvirate: β cell, muscle, liver. A collusion responsible for NIDDM.;DeFronzo;Diabetes,1988

2. Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes.;DeFronzo;Diabetes Rev,1997

3. Effects of weight loss on glucose homeostasis in NIDDM.;Kelley;Diabetes Rev,1995

4. Effects of fitness and physical training on carbohydrate metabolism and associated cardiovascular risk factors in patients with diabetes.;Schneider;Diabetes Rev,1995

5. The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents.;Gulli;Diabetes,1992

Cited by 539 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Astragaloside for Improving Diabetic Vasculopathy Based on Microalbuminuria and C-Reactive Protein;Journal of Biobased Materials and Bioenergy;2024-12-01

2. Managing insulin resistance: the forgotten pathophysiological component of type 2 diabetes;The Lancet Diabetes & Endocrinology;2024-09

3. SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art;American Journal of Cardiovascular Drugs;2024-08-24

4. The impact of GLP-1 signalling on the energy metabolism of pancreatic islet β-cells and extrapancreatic tissues;Peptides;2024-08

5. Metabolic Impairment of Natural Killer Cells in Type 2 Diabetes (T2D) Individuals: A Double-Edged Sword Elevating Susceptibility to Infections and Cancer;Biosciences Biotechnology Research Asia;2024-07-01